Capula Management’s Globus Medical GMED Stock Holding History

Capula Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,328	Closed	-$258K	–	931
2021 Q2	$258K	Buy	+3,328	New	+$237K	﹤0.01%	615

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Capula Management's GMED Position: Q3 2021 in Review

Capula Management sold out of Globus Medical (GMED) in Q3 2021, closing a stake of 3,328 shares — an estimated $258K sold.

Capula Management first reported a position in GMED in Q2 2021 and held it in 1 quarter. The position peaked at $258K in Q2 2021. 388 funds tracked by Wall St. Rank hold GMED as of Q3 2021.

Capula Management reported no remaining Globus Medical position as of Q3 2021 after selling out during the quarter.
Capula Management sold 3,328 Globus Medical shares in Q3 2021, an estimated $258K.
Capula Management first reported a position in Globus Medical in Q2 2021 and held it in 1 quarter.
Capula Management's Globus Medical position peaked at $258K in Q2 2021.
388 funds tracked by Wall St. Rank held Globus Medical as of Q3 2021.

Based on Capula Management's 13F filing for Q3 2021, filed 15 Nov 2021.